Skip to main content
SpringerLink
Log in
Book cover

Coronary Imaging and Physiology pp 177–187Cite as

Bioresorbable Vascular Scaffold Evaluation by Optical Coherence Tomography

  • Chapter
  • First Online:

  • 1841 Accesses

Abstract

Bioresorbable vascular scaffold (BVS) has been introduced as the latest revolution in the field of percutaneous coronary intervention (PCI), which could overcome the long-term limitations of the permanent stent implantation [1]. This device is designed to provide the temporary scaffolding of the vessel before being resorbed completely within the vessel, leaving nothing behind. It makes BVS offer a potential solution to the weakness of drug-eluting stents, which include endothelial dysfunction and hypersensitivity reactions, leading to late stent failure, and disturbance of future surgical revascularization at the same lesion [2–4].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lu C, Filion KB, Eisenberg MJ. The safety and efficacy of absorb bioresorbable vascular scaffold: a systematic review. Clin Cardiol. 2016;39:48–55.

    Article  PubMed  Google Scholar 

  2. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2006;27:166–70.

    Article  PubMed  Google Scholar 

  3. Kay IP, Wardeh AJ, Kozuma K, Foley DP, Knook AH, Thury A, et al. Radioactive stents delay but do not prevent in-stent neointimal hyperplasia. Circulation. 2001;103:14–7.

    Article  CAS  PubMed  Google Scholar 

  4. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519–21.

    Article  CAS  PubMed  Google Scholar 

  5. Fujimoto JG, Boppart SA, Tearney GJ, Bouma BE, Pitris C, Brezinski ME. High resolution in vivo intra-arterial imaging with optical coherence tomography. Heart. 1999;82:128–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Jang IK, Bouma BE, Kang DH, Park SJ, Park SW, Seung KB, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol. 2002;39:604–9.

    Article  PubMed  Google Scholar 

  7. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation. 2002;106:1640–5.

    Article  PubMed  Google Scholar 

  8. Gutiérrez-Chico JL, Gijsen F, Regar E, Wentzel J, de Bruyne B, Thuesen L, et al. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process. JACC Cardiovasc Interv. 2012;5:428–35.

    Article  PubMed  Google Scholar 

  9. Farooq V, Serruys PW, Heo JH, Gogas BD, Onuma Y, Perkins LE, et al. Intracoronary optical coherence tomography and histology of overlapping everolimus eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice. JACC Cardiovasc Interv. 2013;6:523–32.

    Article  PubMed  Google Scholar 

  10. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373:897–910.

    Article  CAS  PubMed  Google Scholar 

  11. Karanasos A, Simsek C, Gnanadesigan M, van Ditzhuijzen NS, Freire R, Dijkstra J, et al. OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold. J Am Coll Cardiol. 2014;64:2343–56.

    Article  PubMed  Google Scholar 

  12. Oberhauser JP, Hossainy S, Rapoza RJ. Design principles and performance of bioresorbable polymeric vascular scaffolds. EuroIntervention. 2009;5:F15–22.

    Article  PubMed  Google Scholar 

  13. Otsuka F, Byrne RA, Yahagi K, Mori H, Ladich E, Fowler DR, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015;36:2147–59.

    Article  PubMed  Google Scholar 

  14. Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Smits PC, et al. Clinical outcomes with bioabsorbable polymer- versusdurable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2014;63:299–307.

    Google Scholar 

  15. Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, et al. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted from a Durable versus Erodable Stent coating) randomized, noninferiority trial. JACC Cardiovasc Interv. 2013;6:777–89.

    Article  PubMed  Google Scholar 

  16. Stefanini GG, Byrne RA, Serruys PW, de Waha A, Meier B, Massberg S, et al. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. Eur Heart J. 2012;33:1214–22.

    Article  CAS  PubMed  Google Scholar 

  17. Yoneda S, Abe S, Kanaya T, Oda K, Nishino S, Kageyama M, et al. Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation. Coron Artery Dis. 2013;24:368–73.

    Article  PubMed  Google Scholar 

  18. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet. 2008;371:899–907.

    Article  CAS  PubMed  Google Scholar 

  19. Onuma Y, Serruys PW, Perkins LE, Okamura T, Gonzalo N, García-García HM, et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation. 2010;122:2288–300.

    Article  CAS  PubMed  Google Scholar 

  20. Brugaletta S, Radu MD, Garcia-Garcia HM, Heo JH, Farooq V, Girasis C, et al. Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque? Atherosclerosis. 2012;221:106–12.

    Article  CAS  PubMed  Google Scholar 

  21. Otsuka F, Pacheco E, Perkins LE, Lane JP, Wang Q, Kamberi M, et al. Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt–chromium XIENCE V stent in a porcine coronary artery model. Circ Cardiovasc Interv. 2014;7:330–42.

    Article  CAS  PubMed  Google Scholar 

  22. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–41.

    Article  PubMed  Google Scholar 

  23. Maehara A, Mintz GS, Weissman NJ. Advances in intravascular imaging. Circ Cardiovasc Interv. 2009;2:482–90.

    Article  PubMed  Google Scholar 

  24. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the international working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59:1058–72.

    Article  PubMed  Google Scholar 

  25. Onuma Y, Sotomi Y, Shiomi H, Ozaki Y, Namiki A, Yasuda S, et al. Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial. EuroIntervention. 2016;12:1090–101.

    Article  PubMed  Google Scholar 

  26. Baquet M, Brenner C, Wenzler M, Eickhoff M, David J, Brunner S, et al. Impact of clinical presentation on early vascular healing after bioresorbable vascular scaffold implantation. J Interv Cardiol. 2016; doi:10.1111/joic.12359.

  27. Sabaté M, Windecker S, Iñiguez A, Okkels-Jensen L, Cequier A, Brugaletta S, et al. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial. Eur Heart J. 2016;37:229–40.

    Article  PubMed  Google Scholar 

  28. Tanimoto S, Serruys PW, Thuesen L, Dudek D, de Bruyne B, Chevalier B, et al. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv. 2007;70:515–23.

    Article  PubMed  Google Scholar 

  29. Takarada S, Imanishi T, Liu Y, Ikejima H, Tsujioka H, Kuroi A, et al. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Cardiovasc Interv. 2010;75:202–6.

    Google Scholar 

  30. Gonzalo N, Serruys PW, García-García HM, van Soest G, Okamura T, Ligthart J, et al. Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries. Rev Esp Cardiol. 2009;62:615–24.

    Article  PubMed  Google Scholar 

  31. Yamaguchi T, Terashima M, Akasaka T, Hayashi T, Mizuno K, Muramatsu T, et al. Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. Am J Cardiol. 2008;101:562–7.

    Article  PubMed  Google Scholar 

  32. Allahwala UK, Cockburn JA, Shaw E, Figtree GA, Hansen PS, Bhindi R. Clinical utility of optical coherence tomography (OCT) in the optimisation of absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention. EuroIntervention. 2015;10:1154–9.

    Article  PubMed  Google Scholar 

  33. Brown AJ, LM MC, Braganza DM, Bennett MR, Hoole SP, West NE. Expansion and malapposition characteristics after bioresorbable vascular scaffold implantation. Catheter Cardiovasc Interv. 2014;84:37–45.

    Article  PubMed  Google Scholar 

  34. Foin N, Alegria E, Sen S, Petraco R, Nijjer S, Di Mario C, et al. Importance of knowing stent design threshold diameters and post-dilatation capacities to optimize stent selection and prevent stent overexpansion/incomplete apposition during PCI. Int J Cardiol. 2013;166:755–8.

    Article  CAS  PubMed  Google Scholar 

  35. Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent trials. JACC Cardiovasc Interv. 2009;2:1269–75.

    Article  PubMed  Google Scholar 

  36. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45:995–8.

    Article  CAS  PubMed  Google Scholar 

  37. Costopoulos C, Latib A, Naganuma T, Miyazaki T, Sato K, Figini F, et al. Comparison of early clinical outcomes between absorb bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population. Catheter Cardiovasc Interv. 2015;85:E10–5.

    Article  PubMed  Google Scholar 

  38. Mattesini A, Secco GG, Dall'Ara G, Ghione M, Rama-Merchan JC, Lupi A, et al. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance. JACC Cardiovasc Interv. 2014;7:741–50.

    Article  PubMed  Google Scholar 

  39. Alegría-Barrero E, Foin N, Chan PH, Syrseloudis D, Lindsay AC, Dimopolous K, et al. Optical coherence tomography for guidance of distal cell recrossing in bifurcation stenting: choosing the right cell matters. EuroIntervention. 2012;8:205–13.

    Article  PubMed  Google Scholar 

  40. Foin N, Ghione M, Mattesini A, Davies JE, Di Mario C. Bioabsorbable scaffold optimization in provisional stenting: insight from optical coherence tomography. Eur Heart J Cardiovasc Imaging. 2013;14:1149.

    Article  PubMed  Google Scholar 

  41. Vaquerizo B, Barros A, Pujadas S, Bajo E, Estrada D, Miranda-Guardiola F, et al. Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study. EuroIntervention. 2015;11:555–63.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, South Korea

    Soo-Joong Kim

Authors
  1. Soo-Joong Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Soo-Joong Kim .

Editor information

Editors and Affiliations

  1. Division of Cardiology, Severance Cardiovascular Hospital , Seoul, Korea (Republic of)

    Myeong-Ki Hong

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Kim, SJ. (2018). Bioresorbable Vascular Scaffold Evaluation by Optical Coherence Tomography. In: Hong, MK. (eds) Coronary Imaging and Physiology. Springer, Singapore. https://doi.org/10.1007/978-981-10-2787-1_18

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-2787-1_18

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-2786-4

  • Online ISBN: 978-981-10-2787-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation